US 8372984
Dual-acting oxazole antihypertensive agents
granted A61KA61K31/421A61K31/422
Quick answer
US patent 8372984 (Dual-acting oxazole antihypertensive agents) held by Theravance, Inc. expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance, Inc.
- Grant date
- Tue Feb 12 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K31/421, A61K31/422, A61K31/4245, A61K31/4439